CITE Assessment

基于 CITE 指标的医院临床指南影响力评估 Hospital Clinical Guideline Impact Assessment Based on the CITE Metric

桥叶草以临床指南引用为依据,评估医院研究如何真正进入临床实践,为医疗机构提供系统、专业的影响力评估服务。 MedBridgeLeaf assesses how hospital research truly enters clinical practice, based on citations in clinical guidelines, and provides systematic, professional impact assessment services for medical institutions.

产品商标:桥叶草 Product: MedBridgeLeaf 评估方法:CITE 指标 Method: CITE 已覆盖:中国与美国医疗机构 Coverage: China and the United States

About

看见研究对临床的真实影响 See the real clinical impact of research

医院的科研能力,不应只看论文数量或传统引用次数。更关键的问题是:这些研究有没有被临床指南采纳,有没有对诊疗决策产生实际作用。

A hospital’s research capacity should not be judged only by publication counts or traditional citation numbers. The more important question is whether the research has been adopted by clinical guidelines, and whether it has genuinely informed clinical decision-making.

桥叶草基于 CITE 指标,围绕临床指南中的引用关系,评估医院研究的临床影响力与时效性,帮助医疗机构理解自身科研如何转化为可被临床采用的价值。

MedBridgeLeaf uses the CITE metric to assess the clinical influence and timeliness of hospital research through citation relationships in clinical guidelines, helping medical institutions understand how their research translates into clinically adopted value.

Value

核心价值 Core Value

01

以指南引用为依据 Grounded in guideline citations

临床指南是临床决策的重要依据。以指南引用评估影响力,更能反映研究是否真正进入诊疗实践。

Clinical guidelines are a key basis for clinical decisions. Measuring impact through guideline citations better reflects whether research has truly entered practice.

02

兼顾影响力与时效性 Influence and timeliness together

既衡量研究被指南采纳的权重,也纳入时效性因素,避免只用静态数量来理解医院的临床贡献。

We consider both the weight of guideline adoption and timeliness, rather than relying on static counts alone to understand a hospital’s clinical contribution.

03

服务医院评价与发展 Supporting hospital evaluation and growth

为医院管理者、学科团队与研究者提供清晰的评估视角,支持科研规划、学科建设与对外交流。

We offer a clear assessment perspective for hospital leaders, specialty teams, and researchers, supporting research planning, discipline development, and external exchange.

Coverage

已覆盖中国与美国医疗机构 Covering medical institutions in China and the United States

评估范围面向中美两地医疗机构,便于在不同医疗体系之间理解临床指南影响力的表现与对标关系。

The assessment covers medical institutions in both China and the United States, making it easier to understand and compare clinical guideline impact across different healthcare systems.

China

中国医疗机构 Medical institutions in China

覆盖中国医院的临床指南影响力评估,帮助理解本土研究在指南中的采纳情况。

We assess the clinical guideline impact of hospitals in China, helping show how local research is adopted in guidelines.

United States

美国医疗机构 Medical institutions in the United States

覆盖美国医疗机构的相应评估,为跨区域比较与合作提供统一的观察框架。

We provide corresponding assessments for U.S. medical institutions, offering a consistent framework for cross-regional comparison and collaboration.